You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tobramycin, Dexamethasone Drug Combination

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Birmingham, Alabama
  • +25 more
Dec 9, 2022

Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Phoenix, Jacksonville, Rochester

Recruiting
  • Plasma Cell Myeloma
  • +3 more
  • Bone Marrow Biopsy
  • +3 more
  • Phoenix, Arizona
  • +2 more
Jan 18, 2023

Multiple Myeloma Trial in United States (ACY-1215, lenalidomide, Dexamethasone)

Completed
  • Multiple Myeloma
  • Boston, Massachusetts
  • +4 more
Feb 7, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (Carfilzomib, Dexamethasone, Pomalidomide)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jun 3, 2022

Coronavirus Infection, Severe Acute Respiratory Infection, Severe Acute Respiratory Syndrome Coronavirus 2 Trial in United

Recruiting
  • Coronavirus Infection
  • +2 more
  • Drug: NA-831
  • +3 more
  • Los Angeles, California
  • +30 more
Jan 31, 2022

Multiple Myeloma Trial in Leicester (CC-92480, Tazemetostat, BMS-986158)

Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +9 more
Oct 24, 2022

Multiple Myeloma Trial in United States (daratumumab, carfilzomib, lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Basking Ridge, New Jersey
  • +6 more
Dec 28, 2022

Multiple Myeloma, Monoclonal Gammopathy of Renal Significance Trial in United States (Cyclophosphamide, Bortezomib,

Recruiting
  • Multiple Myeloma
  • Monoclonal Gammopathy of Renal Significance
  • Basking Ridge, New Jersey
  • +6 more
Oct 16, 2023

Multiple Myeloma in Relapse Trial in Aurora (Selinexor, Pomalidomide, Daratumumab)

Recruiting
  • Multiple Myeloma in Relapse
  • Aurora, Colorado
    University of Colorado Hospital
Jan 31, 2023

Bronchiectasis Adult, Pseudomonas Aeruginosa Infection Trial in China (Tobramycin Inhalant Product, Ciprofloxacin 750 MG, Oral

Recruiting
  • Bronchiectasis Adult
  • Pseudomonas Aeruginosa Infection
  • Tobramycin Inhalant Product
  • +3 more
  • Shanghai, Shanghai, China
  • +59 more
Oct 16, 2023

Multiple Myeloma, Multiple Myeloma in Relapse Trial (Belantamab mafodotin, Venetoclax)

Not yet recruiting
  • Multiple Myeloma
  • Multiple Myeloma in Relapse
  • Belantamab mafodotin, Venetoclax
  • (no location specified)
May 10, 2023

Multiple Myeloma, Relapse, Refractory Trial in Chapel Hill, Winston-Salem, Columbus (Isatuximab, Pomalidomide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • +4 more
  • Chapel Hill, North Carolina
  • +2 more
Jun 9, 2023

Multiple Myeloma Trial in Rochester (procedure, biological, drug)

Not yet recruiting
  • Multiple Myeloma
  • Biospecimen Collection
  • +12 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Sep 15, 2023

Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Venetoclax)

Not yet recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • (no location specified)
Oct 30, 2023

Infections Trial in Salt Lake City (Cephalosporin or clindamycin/vancomycin antibiotics.., Vancomycin and Tobramycin

Enrolling by invitation
  • Infections
  • Cephalosporin or clindamycin/vancomycin antibiotics..
  • Vancomycin and Tobramycin antibiotics.
  • Salt Lake City, Utah
    University of Utah Orthopaedic Center
May 4, 2023

Pediatric Cancer Trial in Yerevan (Ondansetron, Dexamethasone)

Not yet recruiting
  • Pediatric Cancer
  • Yerevan, Armenia
    Hematology Center named after prof. R. Yeolyan
May 23, 2023

ALL, Childhood, Lymphoblastic Lymphoma, Childhood, Lymphoblastic Leukemia, Acute, Childhood Trial in Australia, United States

Recruiting
  • ALL, Childhood
  • +2 more
  • Los Angeles, California
  • +17 more
Aug 11, 2022

Laparoscopic Cholecystectomy, Postoperative Nausea and Vomiting Trial in Banha, Tanta (normal Saline, Dexamethasone,

Not yet recruiting
  • Laparoscopic Cholecystectomy
  • Postoperative Nausea and Vomiting
  • normal Saline
  • +3 more
  • Banhā, Egypt
  • +1 more
Aug 10, 2023

Multiple Myeloma Trial in Detroit, Charlotte (Carfilzomib, Ruxolitinib, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Detroit, Michigan
  • +1 more
Jan 27, 2023

Post Operative Surgical Site Infection Trial in Baltimore (Treatment group, Control group)

Recruiting
  • Post Operative Surgical Site Infection
  • Treatment group
  • Control group
  • Baltimore, Maryland
    University of Maryland Shock Trauma Center
Jul 27, 2022

Multiple Myeloma, Relapsed Cancer, Refractory Multiple Myeloma Trial (ANV419, Lenalidomide with low-dose dexamethasone,

Not yet recruiting
  • Multiple Myeloma
  • +4 more
  • (no location specified)
Nov 29, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Daratumumab, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Yuma, Arizona
  • +150 more
Dec 9, 2022

Myeloma Multiple, Myeloma, Refractory Multiple Myeloma Trial in Brooklyn, New York (Selinexor, Clarithromycin, Pomalidomide)

Terminated
  • Myeloma Multiple
  • +2 more
  • Brooklyn, New York
  • +1 more
Jan 24, 2023

Multiple Myeloma in Relapse Trial in Finland, Sweden (Carfilzomib for Inj 60 milligram (MG), Elotuzumab 400 MG, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma in Relapse
  • Carfilzomib for Inj 60 milligram (MG)
  • +2 more
  • Helsinki, Finland
  • +7 more
Mar 14, 2022

Refractory Multiple Myeloma, Relapsed Multiple Myeloma Trial in Miami (Iberdomide, Carfilzomib, Daratumumab)

Not yet recruiting
  • Refractory Multiple Myeloma
  • Relapsed Multiple Myeloma
  • Miami, Florida
    University of Miami
May 31, 2023